Treatment of type 2 diabetes mellitus in elderly patients

被引：28
|
作者：
Gomez-Huelgas, R. [1 ,2 ,3 ,4 ]
Gomez Peralta, F. [5 ,6 ]
Rodriguez Manas, L. [7 ,8 ,9 ]
Formiga, F. [10 ,11 ]
Puig Domingo, M. [12 ,13 ,14 ,15 ]
Mediavilla Bravo, J. J. [16 ,17 ]
Miranda, C. [18 ,19 ]
Ena, J. [4 ,20 ]
机构：
[1] Univ Malaga, Hosp Reg, Serv Med Interna, Malaga, Spain
[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[3] Inst Salud Carlos III, CIBER Obesidad & Nutr CIBEROBN, Madrid, Spain
[4] SEMI, Madrid, Spain
[5] Hosp Gen Segovia, Unidad Endocrinol & Nutr, Segovia, Spain
[6] SED, Madrid, Spain
[7] Hosp Univ Getafe, Serv Geriatria, Madrid, Spain
[8] Inst Salud Carlos III, CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain
[9] Soc Espanola Med Geriatr SEMEG, Madrid, Spain
[10] Hosp Univ Bellvitge, Unidad Geriatria, Barcelona, Spain
[11] SEGG, Madrid, Spain
[12] Hosp Badalona Germans Trias & Pujol, Serv Endocrinol & Nutr, Barcelona, Spain
[13] Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona, Spain
[14] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain
[15] SEEN, Madrid, Spain
[16] Ctr Salud Burgos Rural, Burgos, Spain
[17] Soc Espanola Med Gen SEMERGEN, Madrid, Spain
[18] Ctr Salud Buenavista, Toledo, Spain
[19] Soc Espanola Med Gen &Familia SEMG, Madrid, Spain
[20] Hosp Marina Baixa, Serv Med Interna, Alicante, Spain
来源：
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 02期
关键词：
Type 2 diabetes mellitus; Elderly; Antidiabetic treatment; RANDOMIZED CLINICAL-TRIAL; BIPHASIC INSULIN ASPART; ONCE-WEEKLY DULAGLUTIDE; CHRONIC KIDNEY-DISEASE; FRAIL OLDER-ADULTS; DOUBLE-BLIND; GLYCEMIC CONTROL; CARDIOVASCULAR OUTCOMES; POOLED ANALYSIS; OPEN-LABEL;
D O I：
10.1016/j.rce.2017.12.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prevalence of type 2 diabetes mellitus (DM2) increases markedly with age. Anti diabetic treatment and the objectives of glycaemic control in elderly patients with DM2 should be individualised according to their biopsychosocial characteristics. In elderly patients for whom the benefits of intensive antidiabetic treatment are limited, the basic objectives should be to improve the quality of life, preserve functionality and avoid adverse effects, especially hypoglycaemia. Treatment of DM2 in the elderly was the subject of a consensus document published in 2012 and endorsed by several Spanish scientific societies. Since then, new therapeutic groups and evidence have emerged that warrant an update to this consensus document. The present document focuses on the therapeutic aspects of DM2 in elderly patients, understood as being older than 75 years or frail. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码：74 / 88
页数：15
相关论文
共 50 条
  • [31] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [32] Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus
    Rukmini Rajagopalan
    Alfonso Perez
    Zhan Ye
    Mehmood Khan
    Frederick T. Murray
    Drugs & Aging, 2004, 21 : 259 - 271
  • [33] The effect of pharmaceutical care in the elderly patients with type 2 diabetes mellitus
    Win Myat Maw
    Mi Mi Saw
    Theingi Kyaw
    Khin Ohnmar Kyaing
    Zaw Min Latt
    KyawZaw Lin
    Aung PyaePhyo
    AsianJournalofPharmaceuticalSciences, 2016, 11 (01) : 93 - 94
  • [34] Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
    Matsumoto, Chisa
    Ogawa, Hisao
    Saito, Yoshihiko
    Okada, Sadanori
    Soejima, Hirofumi
    Sakuma, Mio
    Masuda, Izuru
    Nakayama, Masafumi
    Doi, Naofumi
    Jinnouchi, Hideaki
    Waki, Masako
    Morimoto, Takeshi
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (02)
  • [35] Relationship Between Sarcopenia and Type 2 Diabetes Mellitus in Elderly Patients
    Sayiner, Zeynel Abidin
    Ozturk, Zeynel Abidin
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 23 (01) : 47 - 52
  • [36] Acarbose in the treatment of elderly patients with type 2 diabetes
    Josse, RG
    Chiasson, JL
    Ryan, EA
    Lau, DCW
    Ross, SA
    Yale, JF
    Leiter, LA
    Maheux, P
    Tessier, D
    Wolever, TMS
    Gerstein, H
    Rodger, NW
    Dornan, JM
    Murphy, LJ
    Rabasa-Lhoret, R
    Meneilly, GS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 59 (01) : 37 - 42
  • [37] Depression in the elderly with type 2 diabetes mellitus
    Rymkiewicz, Emilia
    Dzida, Grzegorz
    Myslinski, Wojciech
    Prystupa, Andrzej
    Trojnar, Marcin
    Zakrzewski, Maciej
    Mosiewicz-Madejska, Barbara
    Mosiewicz, Jerzy
    CLINICAL DIABETOLOGY, 2022, 11 (01): : 15 - 19
  • [38] Management of type 2 diabetes mellitus in the elderly
    Soe, Kyaw
    Sacerdote, Alan
    Karam, Jocelyn
    Bahtiyar, Guel
    MATURITAS, 2011, 70 (02) : 151 - 159
  • [39] Effect of statin treatment on mortality in elderly patients with type 2 diabetes mellitus patients: a retrospective cohort study
    Fan, Yao
    Wang, Juan
    Wu, Haidi
    Dai, Lingli
    Wang, Lan
    Gu, Liubao
    BMC GERIATRICS, 2023, 23 (01)
  • [40] Effect of statin treatment on mortality in elderly patients with type 2 diabetes mellitus patients: a retrospective cohort study
    Yao Fan
    Juan Wang
    Haidi Wu
    Lingli Dai
    Lan Wang
    Liubao Gu
    BMC Geriatrics, 23
12345